Should measures be taken to reduce the risk of human parvovirus (B19) infection by transfusion of blood components and clotting factor concentrates?
Mosley
J W
JW
D001779:Blood Coagulation Factors / Q000627:therapeutic use*; D016913:Blood Component Transfusion; D016731:Erythema Infectiosum / Q000517:prevention & control* / Q000635:transmission*; D006801:Humans; D016732:Parvovirus B19, Human / Q000302:isolation & purification
D001779:Blood Coagulation Factors